Drugs News and Research

RSS

Disarmed anthrax toxin tested as a way to combat Covid-19

Disarmed anthrax toxin is being tested as a way of fighting the Covid-19 virus.

28 Apr 2020

Testing the Structural Studies Of Biopolymers with the CPMAS Cryoprobe

In this interview, Program Manager, Alia Hassan and Application Scientist Barbara Perrone, discuss the game-changing sensitivity enhancements achieved with the CPMAS CryoProbe – all the benefits of the CryoProbe, now available for solids.

From Bruker BioSpin Group 28 Apr 2020

Researchers develop a new, promising treatment for HIV

A novel means to prevent HIV infection was developed at the University of Nebraska Medical Center that could allow people with or at risk of acquiring the virus to take medicines once a year.

28 Apr 2020

Astellas and Insilico collaborate on new AI technology to develop new drug candidates

Insilico Medicine has announced that it has entered into a research collaboration agreement with Astellas Pharma Inc. to utilize Insilico Medicine's novel generative artificial intelligence technology aimed at accelerating development of candidates against a conventionally challenging target family.

28 Apr 2020

India's Serum Institute gears up to make millions of doses of potential COVID-19 vaccine

The Serum Institute of India plans to start manufacturing Oxford University's COVID-19 vaccine in 3 weeks to get a head start on production, the company announced. This comes even as experts warn that any successful vaccine will take two or more years to come on the market.

28 Apr 2020

Antibiotic exposure and its priming effect on disease-causing bacteria

Antibiotics save lives -- but using them also helps antibiotic-resistant strains evolve and spread. Each year, antibiotic-resistant bacteria infect some 2.8 million people in the United States, killing more than 35,000, according to the Centers for Disease Control and Prevention.

27 Apr 2020

COVID-19 can trigger serious inflammatory-related cardiovascular problems

The coronavirus disease (COVID-19) is potentially fatal for vulnerable populations like seniors who over 60 years old, and those with underlying medical conditions, like heart disease, diabetes, and lung disease. Reports show that patients are suffering from heart impairment caused by COVID-19. A new study sheds light on the effect of the novel coronavirus on the heart, causing cardiovascular problems, even in those without underlying heart conditions.

27 Apr 2020

Using neutralising antibodies in the fight against COVID-19

While many scientists and pharmaceutical companies are racing to develop a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, there is also an urgent need for a coronavirus disease (COVID-19) treatment. The potent virus has now spread to 210 countries and territories, affecting more than 3.04 million people. Now, a team of German scientists is working on using antibodies to prevent and treat COVID-19.

27 Apr 2020

The approved dose of ivermectin alone not useful in treating COVID-19

A new paper published on the preprint server medRxiv in April 2020 shows that the use of the already approved drug ivermectin in clinical trials to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)s not feasible. This contradicts earlier reports of its ability to suppress the virus in vitro.

27 Apr 2020

New, previously unknown form of familial cold urticaria discovered

Skin rash combined with head and joint pain: these are the symptoms which patients with familial (hereditary) cold urticaria develop when exposed to temperatures below 15 °C.

27 Apr 2020

Gut microbiome influences pattern of activation in rat’s brain during opioid addiction

When Sierra Simpson was in college, she was sick for a year with recurring fevers and vomiting. Her doctors couldn't figure out what she had. Suspecting a bacterial infection, they tried treating her with high doses of antibiotics.

27 Apr 2020

Prolonged corticosteroid treatment increases adrenal gland inflammation

New research by academics at the University of Bristol has found evidence that prolonged treatment of synthetic corticosteroid drugs increases adrenal gland inflammation in response to bacterial infection, an effect that in the long-term can damage adrenal function.

27 Apr 2020

Malaria trial in Namibia finds smart interventions reduce disease transmission by 75%

The researchers published their findings in the prestigious journal The Lancet on World Malaria Day on 25 April even as countries the world over battle to contain transmission of the COVID-19.

27 Apr 2020

Scientists elucidate novel disease processes involved in pulmonary fibrosis development

Working alongside research groups from Heidelberg, researchers from Charité - Universitätsmedizin Berlin have elucidated the novel disease processes involved in the development of pulmonary fibrosis.

27 Apr 2020

Researchers harness the power of AI to accelerate drug discovery

As the COVID-19 crisis continues to develop, researchers around the world are attempting to find the most effective treatment to combat the poorly understood virus behind this disease.

27 Apr 2020

Research provides insights into how Zika virus can spread through sexual contact

Zika virus is capable of replicating and spreading infectious particles within the outermost cells lining the vaginal tract, according to new research. The findings provide the first molecular-level insights into how the virus can move from person to person through sexual contact.

27 Apr 2020

Four drugs that could halt preterm labor identified

As the number of preterm births in the U.S. continues to rise, there is an increasing need for new approaches to prevent preterm labor from progressing to preterm birth. Researchers have discovered a common molecular pathway in women who experience preterm labor and are using this insight to develop new treatments for woman who experience early labor.

27 Apr 2020

Simple blood test offers early warning of chemotherapy-related cardiac dysfunction

Scientists have identified a collection of biomarkers that together signal that a person's cancer treatment may be harming their heart.

27 Apr 2020

Patients with aggressive form of skin cancer can benefit from new type of immunotherapy

In what is believed to be a first-of-its-kind study to evaluate the safety of a type of immunotherapy before surgery in patients with an aggressive form of skin cancer, researchers report that the treatment eliminated pathologic evidence of cancer in nearly half of the study participants undergoing surgery.

27 Apr 2020

Study can lead the way to new treatment methods for hepatitis C in infants

Only about five per cent of the babies born to mothers with hepatitis C are themselves infected by the disease.

27 Apr 2020

Drugs News and Research

Disarmed anthrax toxin tested as a way to combat Covid-19

Testing the Structural Studies Of Biopolymers with the CPMAS Cryoprobe

Researchers develop a new, promising treatment for HIV

Astellas and Insilico collaborate on new AI technology to develop new drug candidates

India's Serum Institute gears up to make millions of doses of potential COVID-19 vaccine

Antibiotic exposure and its priming effect on disease-causing bacteria

COVID-19 can trigger serious inflammatory-related cardiovascular problems

Using neutralising antibodies in the fight against COVID-19

The approved dose of ivermectin alone not useful in treating COVID-19

New, previously unknown form of familial cold urticaria discovered

Gut microbiome influences pattern of activation in rat’s brain during opioid addiction

Prolonged corticosteroid treatment increases adrenal gland inflammation

Malaria trial in Namibia finds smart interventions reduce disease transmission by 75%

Scientists elucidate novel disease processes involved in pulmonary fibrosis development

Researchers harness the power of AI to accelerate drug discovery

Research provides insights into how Zika virus can spread through sexual contact

Four drugs that could halt preterm labor identified

Simple blood test offers early warning of chemotherapy-related cardiac dysfunction

Patients with aggressive form of skin cancer can benefit from new type of immunotherapy

Study can lead the way to new treatment methods for hepatitis C in infants

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News